Advantis Corp.

$0.00+0.00%(+$0.00)
TickerSpark Score
64/100
Mixed
100
Valuation
60
Profitability
100
Growth
30
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ADVT research report →

52-Week Range100% of range
Low $0.00
Current $0.00
High $0.00

Companywww.advantiscorp.com

Advantis Corp. develops and markets products focusing on medical cannabis, research, and pharmaceutical sectors. The company offers pain management and healthcare solutions.

CEO
Darren Cherry
IPO
1996
Employees
5
HQ
Newport Beach, CA, US

Price Chart

+0.00% · this period
$0.00$0.00$0.00May 19Nov 17May 19

Valuation

Market Cap
$9.79K
P/E
-0.41
P/S
0.01
P/B
-0.01
EV/EBITDA
-18.69
Div Yield
0.00%

Profitability

Gross Margin
92.26%
Op Margin
-2.78%
Net Margin
-2.86%
ROE
1.85%
ROIC
4.00%

Growth & Income

Revenue
$826.99K · 103.59%
Net Income
$-23,644 · 79.20%
EPS
$-0.00 · 75.84%
Op Income
$-22,970
FCF YoY
0.00%

Performance & Tape

52W High
$0.00
52W Low
$0.00
50D MA
$0.00
200D MA
$0.00
Beta
-0.83
Avg Volume
118.36K

Get TickerSpark's AI analysis on ADVT

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our ADVT Coverage

We haven't published any research on ADVT yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate ADVT Report →

Similar Companies